Matches in Wikidata for { <http://www.wikidata.org/entity/Q38170834> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- Q38170834 description "article científic" @default.
- Q38170834 description "article scientifique" @default.
- Q38170834 description "articol științific" @default.
- Q38170834 description "articolo scientifico" @default.
- Q38170834 description "artigo científico" @default.
- Q38170834 description "artigo científico" @default.
- Q38170834 description "artigo científico" @default.
- Q38170834 description "artikel ilmiah" @default.
- Q38170834 description "artikull shkencor" @default.
- Q38170834 description "artículo científico" @default.
- Q38170834 description "artículu científicu espublizáu en 2013" @default.
- Q38170834 description "bilimsel makale" @default.
- Q38170834 description "scienca artikolo" @default.
- Q38170834 description "scientific article published on December 2013" @default.
- Q38170834 description "scientific article published on December 2013" @default.
- Q38170834 description "scientific article published on December 2013" @default.
- Q38170834 description "vedecký článok" @default.
- Q38170834 description "vetenskaplig artikel" @default.
- Q38170834 description "videnskabelig artikel" @default.
- Q38170834 description "vitenskapelig artikkel" @default.
- Q38170834 description "vitskapeleg artikkel" @default.
- Q38170834 description "vědecký článek" @default.
- Q38170834 description "wetenschappelijk artikel" @default.
- Q38170834 description "wissenschaftlicher Artikel" @default.
- Q38170834 description "наукова стаття, опублікована в грудні 2013" @default.
- Q38170834 description "научная статья" @default.
- Q38170834 description "научни чланак" @default.
- Q38170834 description "מאמר מדעי" @default.
- Q38170834 description "مقالة علمية نشرت في ديسمبر 2013" @default.
- Q38170834 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38170834 name "Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials." @default.
- Q38170834 name "Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials." @default.
- Q38170834 name "Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials." @default.
- Q38170834 type Item @default.
- Q38170834 label "Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials." @default.
- Q38170834 label "Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials." @default.
- Q38170834 label "Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials." @default.
- Q38170834 prefLabel "Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials." @default.
- Q38170834 prefLabel "Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials." @default.
- Q38170834 prefLabel "Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials." @default.
- Q38170834 P1433 Q38170834-B0796499-39B6-4678-86CF-59BF245589AE @default.
- Q38170834 P1476 Q38170834-3DAACD08-E3EC-42B5-AF54-B76E06A05E56 @default.
- Q38170834 P2093 Q38170834-1F096186-23D3-4AB2-8EE0-5B8C83AFDF1B @default.
- Q38170834 P2093 Q38170834-63EE1C36-DF12-4E81-B31F-28E4781AEEF7 @default.
- Q38170834 P2093 Q38170834-70480EDF-AAC9-4CE6-9F9B-F848002A7DC9 @default.
- Q38170834 P2093 Q38170834-9AA592EA-EB44-4B5E-87FC-6578EEA1674F @default.
- Q38170834 P304 Q38170834-67438382-3974-46A0-974E-E83447AB667E @default.
- Q38170834 P31 Q38170834-060a4be9-1237-461c-b7ea-8c0f55acb109 @default.
- Q38170834 P31 Q38170834-0D52A779-3D35-4ADA-8E75-5336AD806308 @default.
- Q38170834 P356 Q38170834-E4C6DB0C-C2E0-4233-830B-6DA85839C235 @default.
- Q38170834 P433 Q38170834-060805B7-1286-4EB2-90B8-8CA28D709939 @default.
- Q38170834 P478 Q38170834-D474C52F-2CB6-4C51-80C4-60F43DEA0126 @default.
- Q38170834 P50 Q38170834-2DFF05CD-AEEF-4368-A876-FA1C684676BB @default.
- Q38170834 P50 Q38170834-6CC1FCB8-8DCB-47A9-BA52-F7577FCD55ED @default.
- Q38170834 P50 Q38170834-948DBB81-5389-43F7-B847-2C22682D22BA @default.
- Q38170834 P50 Q38170834-D8D9904E-9980-4917-BC8C-0B759F89B0B4 @default.
- Q38170834 P50 Q38170834-DDF9654D-F7C9-4053-A641-4FBFFC0C1344 @default.
- Q38170834 P50 Q38170834-DF79A101-5D56-4229-BAEF-AF0870272AF6 @default.
- Q38170834 P50 Q38170834-F8F2898E-43A4-408A-8C75-4BD121971493 @default.
- Q38170834 P577 Q38170834-37B9E04C-F826-422D-957C-8524A1EE226E @default.
- Q38170834 P698 Q38170834-577CD710-E09B-48B2-970B-E1257320272A @default.
- Q38170834 P921 Q38170834-14D38846-4F96-475B-8352-BD03D897A5F7 @default.
- Q38170834 P921 Q38170834-FC28C463-06E8-40B6-8DB8-4062B197BFE4 @default.
- Q38170834 P356 J.CRITREVONC.2013.11.005 @default.
- Q38170834 P698 24332915 @default.
- Q38170834 P1433 Q15724423 @default.
- Q38170834 P1476 "Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials" @default.
- Q38170834 P2093 "Filippo De Marinis" @default.
- Q38170834 P2093 "Matteo Brunelli" @default.
- Q38170834 P2093 "Stefania Kinspergher" @default.
- Q38170834 P2093 "Umberto Peretti" @default.
- Q38170834 P304 "135-145" @default.
- Q38170834 P31 Q13442814 @default.
- Q38170834 P31 Q815382 @default.
- Q38170834 P356 "10.1016/J.CRITREVONC.2013.11.005" @default.
- Q38170834 P433 "2" @default.
- Q38170834 P478 "90" @default.
- Q38170834 P50 Q37383620 @default.
- Q38170834 P50 Q38544270 @default.
- Q38170834 P50 Q44736865 @default.
- Q38170834 P50 Q46978152 @default.
- Q38170834 P50 Q56380768 @default.
- Q38170834 P50 Q62554605 @default.
- Q38170834 P50 Q72107595 @default.
- Q38170834 P577 "2013-12-01T00:00:00Z" @default.
- Q38170834 P698 "24332915" @default.
- Q38170834 P921 Q356033 @default.
- Q38170834 P921 Q6822263 @default.